GSK's (GSK) stock rises as the company's Arexvy shot could see expanded CDC recommendations for RSV protection in at-risk adults aged 50-59 this week. Read more here.

"It's early to call heads or tails or direction of travel on how this will play out," CEO David Solomon said of Washington's ...

In a report released on April 11, Salveen Richter from Goldman Sachs maintained a Buy rating on Regeneron (REGN – Research Report), with a ...

Goldman Sachs reported revenue drops in two of its three main business lines, but trading revenue was enough to satisfy ...

Goldman Sachs (NYSE:GS) reported higher first-quarter results, with revenue of $15.06 billion beating expectations at $14.81 ...

Goldman Sachs raised the odds of a U.S. recession to 45% from 35%, the second time it has increased its forecast in a week, ...

ROME (Reuters) - A pool of banks led by Goldman Sachs is ready to give Prada a 2.5-billion-euro ($2.77 billion) financing ...